Scisparc Financials

SPRC Stock  USD 0.37  0.01  2.63%   
Based on the measurements of operating efficiency obtained from Scisparc's historical financial statements, Scisparc is not in a good financial situation at this time. It has a very high odds of going through financial crisis in April. At present, Scisparc's Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 339.9 K, whereas Common Stock Shares Outstanding is forecasted to decline to about 348.8 K. Key indicators impacting Scisparc's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.00850.009
Notably Down
Slightly volatile
Current Ratio4.664.72
Fairly Down
Slightly volatile
The essential information of the day-to-day investment outlook for Scisparc includes many different criteria found on its balance sheet. An individual investor should monitor Scisparc's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Scisparc.

Net Income

(4.84 Million)

  
Please note, the presentation of Scisparc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Scisparc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Scisparc's management manipulating its earnings.

Scisparc Stock Summary

Scisparc competes with Virax Biolabs, ZyVersa Therapeutics, Unicycive Therapeutics, Quoin Pharmaceuticals, and Cardio Diagnostics. SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel. Scisparc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINIL0010951403
CUSIP88339A203 M82618105 M82618113 80909J102
LocationIsrael
Business AddressTower A, Tel
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitescisparc.com
Phone972 7 334 47180
CurrencyUSD - US Dollar

Scisparc Key Financial Ratios

Scisparc Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets2.6M9.9M10.6M11.2M12.9M13.5M
Other Current Liab666K830K3.8M1.3M1.4M942.0K
Net Debt(1.5M)(6.4M)(3.5M)(2M)(1.8M)(1.9M)
Retained Earnings(55.2M)(61.0M)(63.6M)(68.7M)(61.8M)(64.9M)
Accounts Payable277K441K298K264K303.6K339.9K
Cash1.9M6.9M3.6M2.1M2.4M3.0M
Net Receivables286K2.6M168K287K330.1K428.6K
Other Current Assets318K393K100K340K391K213.2K
Total Liab1.1M1.8M4.2M1.6M1.8M1.8M
Total Current Assets2.6M9.8M4.5M6.4M7.4M4.0M
Common Stock49.0M58.5M58.6M64.5M74.2M77.9M
Net Tangible Assets14K1.4M8.1M1.7M1.6M2.7M
Net Invested Capital1.9M8.6M6.4M7.6M8.8M5.5M
Net Working Capital1.4M8.1M354K4.9M5.6M3.3M
Capital Stock49.0M58.5M58.6M64.5M74.2M44.2M
Short Term Debt188K486K27K52K46.8K44.5K

Scisparc Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense25K12K36K9K10.4K9.8K
Operating Income(3.3M)(5.8M)(7.4M)(5.8M)(5.2M)(5.5M)
Ebit(2.6M)(5.8M)(2.4M)(5.9M)(5.3M)(5.5M)
Research Development649K2.0M2.8M1.6M1.9M1.7M
Ebitda(2.4M)(5.7M)(2.2M)(5.3M)(4.8M)(5.0M)
Income Before Tax(3.5M)(5.8M)(2.6M)(5.9M)(5.3M)(5.5M)
Net Income(3.5M)(5.8M)(2.6M)(5.1M)(4.6M)(4.8M)
Income Tax Expense(28K)12K14K22K25.3K24.0K
Gross Profit386K1.0M1.0M2.2M2.5M2.7M
Cost Of Revenue164K33K322K683K785.5K824.7K
Net Interest Income(230K)(18K)(1.2M)(9K)(8.1K)(8.5K)
Total Revenue550K1.1M1.3M2.9M3.3M3.5M
Minority Interest426K(108K)53K761K875.2K918.9K

Scisparc Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash1.1M4.9M(3.3M)(1.5M)(1.7M)(1.6M)
Free Cash Flow(4.3M)(5.1M)(12.8M)(5.9M)(5.3M)(5.6M)
Depreciation164K33K187K538K618.7K649.6K
Other Non Cash Items(476K)9K(5.7M)(666K)(599.4K)(629.4K)
Net Income(3.5M)(5.8M)(2.6M)(5.1M)(4.6M)(4.8M)
End Period Cash Flow1.9M6.9M3.6M2.1M2.4M2.8M
Investments24K(70K)(7.1M)(1.1M)(998.1K)(1.0M)
Net Borrowings(47K)224K(207K)(70K)(63K)(59.9K)
Change To Netincome2.0M357K52K(4.8M)(4.3M)(4.1M)
Change To Inventory519K(170K)(668K)(74K)(66.6K)(63.3K)

Scisparc Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Scisparc's current stock value. Our valuation model uses many indicators to compare Scisparc value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Scisparc competition to find correlations between indicators driving Scisparc's intrinsic value. More Info.
Scisparc is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Scisparc's Return On Equity is projected to drop based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Scisparc's earnings, one of the primary drivers of an investment's value.

Scisparc Systematic Risk

Scisparc's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Scisparc volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Scisparc correlated with the market. If Beta is less than 0 Scisparc generally moves in the opposite direction as compared to the market. If Scisparc Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Scisparc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Scisparc is generally in the same direction as the market. If Beta > 1 Scisparc moves generally in the same direction as, but more than the movement of the benchmark.

About Scisparc Financials

What exactly are Scisparc Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Scisparc's income statement, its balance sheet, and the statement of cash flows. Potential Scisparc investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Scisparc investors may use each financial statement separately, they are all related. The changes in Scisparc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Scisparc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Today, most investors in Scisparc Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Scisparc's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Scisparc growth as a starting point in their analysis.

Price Earnings To Growth Ratio

0.2

At present, Scisparc's Price Earnings To Growth Ratio is projected to increase significantly based on the last few years of reporting.

Scisparc March 18, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Scisparc help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Scisparc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Scisparc based on widely used predictive technical indicators. In general, we focus on analyzing Scisparc Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Scisparc's daily price indicators and compare them against related drivers.

Complementary Tools for Scisparc Stock analysis

When running Scisparc's price analysis, check to measure Scisparc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scisparc is operating at the current time. Most of Scisparc's value examination focuses on studying past and present price action to predict the probability of Scisparc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scisparc's price. Additionally, you may evaluate how the addition of Scisparc to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators